Multiple Sclerosis
Earlier use of targeted therapies may delay MS disease progression over 5 years
ORLANDO, Fla. — Patients with MS who developed paramagnetic rim lesions declined more rapidly, but implementing disease-modifying therapies earlier could reduce the burden of disease progression, data show.
Surveillance of the vascular access leads to better outcomes for patients, payers
Patients on hemodialysis require functioning access sites, yet all access sites are at risk of stenosis and subsequent failure.
Virtual nephrology mentorship program boosts residency, fellowship enrollment rates
Individuals who participated in a virtual nephrology mentorship program had high enrollment rates in nephrology pipeline residencies and fellowships, study results showed.
Novel AI model may predict which patients with cancer are at risk for chronic pain
A multi-institutional team of researchers developed an AI model designed to predict which patients with breast cancer are most likely to experience chronic pain.
Tolebrutinib delays onset of MS disability progression in phase 3 trial
An oral brain-penetrant therapeutic delayed the onset of confirmed disability progression compared with placebo in those with non-relapsing secondary progressive MS, according to results from a phase 3 study.
Single cell-free DNA test accurately detects fetal antigen status in alloimmunized women
Cell-free DNA analyses were accurate in detecting fetal antigen status as early as 10 weeks’ gestation in women with alloimmunized pregnancies, according to results of a large, diverse U.S. cohort study published in Obstetrics & Gynecology.
Apixaban, aspirin comparable for patients with cancer history, cryptogenic stroke
Apixaban and aspirin offered similar protection against major ischemic and hemorrhagic events among people with cancer history and cryptogenic stroke.
FDA clears clinical trial on novel MS cell therapy platform
The FDA has cleared an investigational new drug application for a phase 1 clinical trial evaluating a universal, allogenic cell therapy platform intended to treat progressive MS.
‘Quite striking’: Donor socioeconomic status may affect stem cell transplant outcomes
The socioeconomic status of cell donors may affect outcomes of people with blood cancer who undergo hematopoietic stem cell transplantation, according to retrospective study results.
Cardiovascular, thromboembolic events more closely tied to kidney vs. glomerular disease
Incident cardiovascular and thromboembolic events may be more closely linked to the severity of kidney disease than with glomerular disease subtype, according to results of a prospective study.